374 Water Inc. SCWO
We take great care to ensure that the data presented and summarized in this overview for 374Water Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SCWO
View all-
Black Rock Inc. New York, NY3.83MShares$2.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$2.39 Million0.0% of portfolio
-
Hamilton Lane Advisors LLC1.62MShares$1.12 Million2.35% of portfolio
-
Geode Capital Management, LLC Boston, MA1.56MShares$1.07 Million0.0% of portfolio
-
Icon Wealth Partners, LLC1.15MShares$791,1620.16% of portfolio
-
State Street Corp Boston, MA969KShares$668,3560.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC642KShares$443,2740.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA499KShares$343,9850.0% of portfolio
-
Northern Trust Corp Chicago, IL485KShares$334,3610.0% of portfolio
-
D.A. Davidson & Co.433KShares$298,4490.0% of portfolio
Latest Institutional Activity in SCWO
Top Purchases
Top Sells
About SCWO
374Water, Inc. focuses on providing a technology that addresses environmental pollution challenges. It develops a waste stream treatment system based on supercritical water oxidation technology. The company's AirSCWO systems are used to treat various hazardous and non-hazardous waste streams. Its clients include channel partners, such as engineering-procurement and construction companies, technology integrators, waste service providers, operations service providers, and NGOs; and end-users, which include utilities, industrial manufacturing facilities, waste management and environmental remediation companies, agricultural companies, and governmental entities. The company is based in Durham, North Carolina.
Insider Transactions at SCWO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2024
|
Richard H Davis |
SELL
Payment of exercise price or tax liability
|
Direct |
179,105
-13.54%
|
$0
$0.67 P/Share
|
|
Dec 30
2024
|
Richard H Davis |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000,000
+43.05%
|
$0
$0.12 P/Share
|
|
Nov 18
2024
|
Richard H Davis |
BUY
Open market or private purchase
|
Indirect |
40,000
+19.95%
|
$40,000
$1.25 P/Share
|
|
Nov 18
2024
|
Chris M Gannon President & CEO |
BUY
Open market or private purchase
|
Direct |
120,000
+50.0%
|
$120,000
$1.25 P/Share
|
|
Nov 18
2024
|
Marc Deshusses |
BUY
Open market or private purchase
|
Direct |
32,000
+0.14%
|
$32,000
$1.25 P/Share
|
|
Nov 18
2024
|
Buddie J Penn |
BUY
Open market or private purchase
|
Direct |
20,000
+25.0%
|
$20,000
$1.25 P/Share
|
|
Nov 18
2024
|
Adrienne Anderson Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+12.23%
|
$10,000
$1.25 P/Share
|
|
Nov 18
2024
|
Deanna Rene Estes |
BUY
Open market or private purchase
|
Direct |
24,000
+23.88%
|
$24,000
$1.25 P/Share
|
|
Nov 18
2024
|
James Michael Vanderhider |
BUY
Open market or private purchase
|
Indirect |
250,000
+14.97%
|
$250,000
$1.25 P/Share
|
|
Nov 18
2024
|
Peter Mandel General Counsel |
BUY
Open market or private purchase
|
Direct |
10,800
+4.01%
|
$10,800
$1.25 P/Share
|
|
Nov 15
2024
|
Richard H Davis |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+11.02%
|
-
|
|
Nov 15
2024
|
Terry Merrell |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
|
Nov 15
2024
|
Buddie J Penn |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
|
Nov 15
2024
|
Adrienne Anderson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,762
+47.37%
|
-
|
|
Nov 15
2024
|
Deanna Rene Estes |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+43.24%
|
-
|
|
Nov 15
2024
|
James Michael Vanderhider |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
|
Nov 15
2024
|
Peter Mandel General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
247,775
+50.0%
|
-
|
|
Nov 14
2024
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct |
8,563
-0.02%
|
$8,563
$1.41 P/Share
|
|
Nov 13
2024
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct |
30,121
-0.08%
|
$30,121
$1.42 P/Share
|
|
Nov 12
2024
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct |
4,252
-0.01%
|
$4,252
$1.51 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 510K shares |
|---|---|
| Open market or private purchase | 507K shares |
| Exercise of conversion of derivative security | 1M shares |
| Open market or private sale | 590K shares |
|---|---|
| Payment of exercise price or tax liability | 179K shares |